Ledger.Open graph →
SEC Form D · filed August 11, 2023

Poseida Therapeutics, Inc

Offering
$25.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Mark J. Gergen · San Diego, CAExec · DirectorJohn B. Schmid · San Diego, CADirectorRafael J. Amado · San Diego, CADirectorHarry J. Leonhardt · San Diego, CAExecJohanna M. Mylet · San Diego, CAExecLuke M. Corning · San Diego, CADirectorCynthia M. Collins · San Diego, CADirectorMarcea B. Lloyd · San Diego, CADirectorBrent J. Warner · San Diego, CAExecCharles M. Baum · San Diego, CADirectorKristin J. Yarema · San Diego, CAExecRafael J. Amado · San Diego, CADirectorHarry J. Leonhardt · San Diego, CAExecMark J. Gergen · SAN DIEGO, CAExec · DirectorJohanna M. Mylet · San Diego, CAExecLuke M. Corning · San Diego, CADirectorCynthia M. Collins · San Diego, CADirectorMarcea B. Lloyd · San Diego, CADirectorBrent J. Warner · San Diego, CAExecCharles M. Baum · San Diego, CADirectorKristin J. Yarema · San Diego, CAExecJohn B. Schmid · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗